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921The regurgitant volume of TR might increase dynamically despite
unchanged effective regurgitant oriﬁce area, thus exaggerating TR
severity on echocardiographic assessment. Meanwhile, functional
TR from various chronic and acute cardiomyopathies may sig-
niﬁcantly reverse either by itself or after medical treatment. Thus,
integrated analysis on both cardiac imaging and clinical data of
functional TR is requested before surgical decisions are made.
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Bicuspid Aortic Valve Phenotype
and Aortopathy: Nomenclature
and Role of Aortic Hemodynamics
We read with great interest the recently published paper by Kang
et al. (1) regarding the importance of bicuspid aortic valve (BAV)
phenotypic classiﬁcation and its association with valvular dysfunction
and aortopathy. The ﬁndings provide new and valuable data
regarding risk stratiﬁcation of BAV patients according to leaﬂet
morphology. Of particular interest is the potential utility of this in-
formation, combined with knowledge of family history and hemo-
dynamics (2), to provide a better understanding of patient prognosis.
Unfortunately, in the context of the existing literature, the au-
thors chose unconventional nomenclature to stratify BAV phe-
notypes. In the paper, the term BAV-RL designates valves with
free leaﬂets in the lateral position rather than the more common
practice of describing fusion of the right and left coronary leaﬂets
(3–5). Although somewhat arbitrary, this terminology contradicts
the classiﬁcation scheme adapted from one of the key references
(3) and produces yet another naming scheme. The question of
what constitutes a BAV-RL is sure to cause confusion amongst the
community and in future research efforts where nomenclature
swapping propagates and goes unnoticed. This highlights a
growing need for a uniform classiﬁcation scheme, similar to that
proposed by Sievers et al. (4).
Furthermore, the discussion of aortic hemodynamic changes as a
potential link between valve morphology and development of aort-
opathy is somewhat incomplete. Although we strongly agree that
BAVs alter aortic hemodynamics, as has recently been shown by usand others, the assertion that left-handed helical ﬂow exists in the
BAV phenotype with free leaﬂets in the lateral position is unproven,
with a single-center report in the literature.
Our experience is that the orientation of the ﬂow helix is pre-
dominantly right-handed. We and others have shown that the
incomplete opening of the BAV results in an abnormal ﬂow jet
dependent on the position of a conjoint leaﬂet. In the case of lateral
leaﬂet fusion, the conjoint leaﬂet can cause a ﬂow jet to reﬂect off of
the inner arch curvature and impinge on the greater arch at a more
downstream position, thereby causing helical ﬂow with right-handed
orientation (5). In addition, the authors did not address recent de-
velopments that have shown that magnetic resonance imaging can be
used to directly quantify the impact of aortic valve disease on the
aortic wall by means of metrics such as segmental wall shear stress (5).
In this context, aortic wall shear stress is altered regardless of the
orientation of helix ﬂow and may be a more fundamental parameter
to investigate for abnormal aortic remodeling.
In essence, we believe that the data of Kang et al. (1) are an
important step toward understanding the role genetics and
mechanotransduction may play in BAV-mediated aortopathy. We
agree that advanced imaging techniques offer promising diagnostic
imaging tools. However, a consistent description of the subtle var-
iations in valve morphology, as well as newly developed in vivo
metrics of hemodynamic changes associated with aortic valve dis-
ease, should not be overlooked: without a uniform classiﬁcation
scheme, we run the risk of confounding future efforts.
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REPLY : Bicuspid Aortic Valve Phenotype and Aortopathy:
Nomenclature and Role of Aortic Hemodynamics
We thank for Drs. Barker, Robinson, and Markl for their interest in
our paper (1). They were concerned about the potential confusion
caused by our using the term BAV-RL to designate the spatial
orientation of a bicuspid aortic valve (BAV) in cases where the right
or left coronary cusp is fused with the noncoronary cusp. They
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922mentioned that most investigators have used BAV-RL to designate
valves with fusion of the right and left coronary cusps. Although it is
correct that classiﬁcations based on the speciﬁc cusps that are fused
may be more commonly used, we believe that the BAV phenotype
can also be classiﬁed by mentioning the spatial orientation after
fusion. Sometimes, it may in fact be impossible to determine the
individual cusps involved. Furthermore, phenotype classiﬁcation
using spatial orientation (BAV-RL versus BAV-AP) may better
represent the functional signiﬁcance. Such classiﬁcation has been
used before, for example, in embryological (2) and imaging research
(3,4). To avoid confusion, we made sure to explain the terms used in
our paper (BAV-RL and BAV-AP) in the table and ﬁgure legends.
The potential association between the ﬂow helix in the aorta and
aortopathy type in patients with BAV is another very important
topic (5). The predominant pattern of the ﬂow helix may well be
dependent on BAV phenotype. Dr. Barker and colleagues showed
that the orientation of the ﬂow helix is predominantly right-handed,
but they predominantly analyzed patients with 1 speciﬁc pattern
(fusion of the right and left coronary cusps, 12 of 15 patients).
Previous observations have shown that right-handed helical ﬂow is
predominant in BAV patients with fusion of the right and left cusps,
as opposed to left-handed helical ﬂow in BAV patients with fusion
of the right and noncoronary cusps. Thus, we believe that our
statement regarding a potential association between BAV phenotype
and helical ﬂow orientation has valid support from scientiﬁc ob-
servations by other investigators.
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MDCT in TAVR for Better Implant
Angle and Outcomes
We read with interest the paper by Samim et al. (1) on the use of
automated 3-dimensional analysis of pre-procedural multidetector
computed tomography (MDCT) to predict an optimal C-arm angle
for transcatheter aortic valve replacement (TAVR) and the potential
improvement in outcomes.Previous research (2) had shown that pre-procedural MDCT can
provide accurate operator-deﬁned optimized implant angles (OIAs) and
that implant angle prediction is related to MDCT image quality. Rota-
tional angiography intraprocedurally predicts the OIA even more accu-
rately than doesMDCT (3,4), and an OIA appears to be associated with
less paravalvular regurgitation (PVR) (4).
We have several comments on the study design. The authors inge-
niously attempted to mitigate the confounding impact of operator
experience by randomly assigningpatients fromDecember2009 to June
2011 into angiography (Cohort B) andMDCT(CohortA) cohorts in a
1:4 fashion, respectively. In chronologically spaced research in which
operator experience likely matters, it is almost impossible to completely
mitigate bias. Cohort B patients had numerically lower implantation
time and contrast and radiation exposuredwere the 11 and 24 patients
in Cohorts B and A, respectively, sufﬁcient to deﬁnitively exclude this
potential bias? Operator experience had previously been linked with
procedural outcomes. Further analysis in a larger cohort from this
randomized cohort (MDCT vs. B) may be worthwhile.
Second, the studymandated that an aortogramnot be performedup
front in theMDCT group, and this at least partially accounted for the
procedural parameter difference. Nonetheless, remarkably, no
MDCT cohort patient needed more than one aortogram, whilst 89%
of angiography-cohort patients needed more than one aortogram.
Last, issues on beneﬁt on clinical outcome. We are unclear
regarding the reduced need for balloon post-dilation in the MDCT
cohortdas this is not related to valve malpositioning per se, which
would potentially be a consequence of a poor implant ﬂuoroscopic
angle. The study unfortunately did not correct for potential con-
founders such as valve undersizing and valve calciﬁcation, particularly
with regard to outcomes such as PVR.
MDCT improves TAVR sizing and most data suggest a
reduction in PVR. The idea of “better angle, better outcomes” seems
intuitive but more data is needed. Further data to conﬁrm the overall
clinical outcome improvement from MDCT is eagerly awaited.
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